Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;12(3):512-522.
doi: 10.1002/acn3.52291. Epub 2025 Jan 24.

Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy

Affiliations

Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy

Ermelinda De Meo et al. Ann Clin Transl Neurol. 2025 Mar.

Abstract

Objectives: We aim to investigate cognitive phenotype distribution and MRI correlates across pediatric-, elderly-, and adult-onset MS patients as a function of disease duration.

Methods: In this cross-sectional study, we enrolled 1262 MS patients and 238 healthy controls, with neurological and cognitive assessments. A subset of 222 MS patients and 92 controls underwent 3T-MRI scan for brain atrophy and lesion analysis. Multinomial probabilistic models identified likelihood of belonging to cognitive phenotypes ("preserved-cognition," "mild verbal memory/semantic fluency," "mild multi-domain," "severe attention/executive," and "severe multi-domain") and experiencing MRI abnormalities based on disease duration and age at onset.

Results: In all groups, the likelihood of "preserved-cognition" phenotype decreased, whereas "mild multi-domain" increased with longer disease duration. In pediatric- and adult-onset patients, the likelihood of "mild verbal memory/semantic fluency" phenotypes decreased with longer disease duration, and that of "severe multi-domain" increased with longer disease duration. Only in adult-onset patients, the likelihood of "severe executive/attention" phenotype increased with longer disease duration. All groups displayed escalating probabilities of cortical, thalamic, hippocampal, and deep gray matter atrophy over disease course. Compared to adult, pediatric-onset patients showed lower probability of experiencing thalamic atrophy with longer disease duration, while elderly-onset showed higher probability of experiencing cortical and hippocampal atrophy.

Interpretation: Age at MS onset significantly influences the distribution of cognitive phenotypes and the patterns of regional gray matter atrophy throughout the disease course.

PubMed Disclaimer

Conflict of interest statement

All the authors report no conflict of interest related to the present study.

Figures

Figure 1
Figure 1
Cognitive phenotypes over increasing disease duration. Summarizes predicted probabilities to belong to each phenotype over increasing disease duration in patients grouped according to the age at disease onset. Pediatric onset = red, adult onset = green, elderly onset = blue.
Figure 2
Figure 2
Lesion volume and gray matter atrophy over increasing disease duration. Summarizes predicted probabilities to overcome the median value of lesion volume distribution and to experience gray matter atrophy in cortex, thalamus, hippocampus, and deep gray matter over increasing disease duration in patients grouped according to the age at disease onset. Pediatric onset = red, adult onset = green, elderly onset = blue.
Figure 3
Figure 3
Significant differences between pediatric‐, adult‐ and elderly‐onset. Significant differences among the three groups at 1, 10, and 20 years of disease duration are reported. The probability of experiencing atrophy is shown on a yellow‐black scale. AOMS, adult‐onset multiple sclerosis; EOMS, elderly‐onset multiple sclerosis; POMS, pediatric onset multiple sclerosis.

References

    1. Tremlett H, Devonshire V. Is late‐onset multiple sclerosis associated with a worse outcome? Neurology. 2006;67:954‐959. doi:10.1212/01.wnl.0000237475.01655.9d - DOI - PubMed
    1. Vaughn CB, Jakimovski D, Kavak KS, et al. Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol. 2019;15:329‐342. doi:10.1038/s41582-019-0183-3 - DOI - PubMed
    1. Alroughani R, Boyko A. Pediatric multiple sclerosis: a review. BMC Neurol. 2018;18(27):20180309. doi:10.1186/s12883-018-1026-3 - DOI - PMC - PubMed
    1. Naseri A, Nasiri E, Sahraian MA, Daneshvar S, Talebi M. Clinical features of late‐onset multiple sclerosis: a systematic review and meta‐analysis. Mult Scler Relat Disord. 2021;50:102816. doi:10.1016/j.msard.2021.102816 - DOI - PubMed
    1. De Meo E, Filippi M, Trojano M, et al. Comparing natural history of early and late onset pediatric multiple sclerosis. Ann Neurol. 2022;91:483‐495. doi:10.1002/ana.26322 - DOI - PubMed

MeSH terms

LinkOut - more resources